Echo Therapeutics (ECTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 429 | 1,332 | 0 | 58 | 89 |
| Cost of Goods | N/A | N/A | N/A | 2 | 91 |
| Gross Profit | 429 | 1,332 | N/A | 56 | -2 |
| Operating Expenses | 5,339 | 5,862 | 6,927 | 12,903 | 4,983 |
| Operating Income | -4,911 | -4,531 | -6,927 | -12,845 | -5,445 |
| Interest Expense | 38 | 332 | 1,050 | 436 | 20 |
| Other Income | 1,565 | -6,096 | -6,288 | 56 | 676 |
| Pre-tax Income | -3,383 | -10,958 | -14,264 | -13,226 | -4,790 |
| Net Income Continuous | -3,383 | -10,958 | -14,264 | -13,226 | -4,790 |
| Net Income | $-4,147 | $-10,958 | $-10,596 | $-13,226 | $-5,341 |
| EPS Basic Total Ops | -1.50 | -6.10 | -5.70 | -11.20 | -19.70 |
| EPS Basic Continuous Ops | -1.17 | -4.92 | -7.67 | -11.24 | -17.61 |
| EPS Diluted Total Ops | -1.50 | -6.10 | -5.70 | -11.20 | -19.70 |
| EPS Diluted Continuous Ops | -1.17 | -4.92 | -7.67 | -11.22 | -17.61 |
| EBITDA(a) | $-4,801 | $-4,372 | $-6,735 | $-12,694 | $-4,710 |